Qilian International Holding Group Limited (QLI)
| Market Cap | 136.21M |
| Revenue (ttm) | 52.21M |
| Net Income (ttm) | 3.56M |
| Shares Out | 32.43M |
| EPS (ttm) | 0.11 |
| PE Ratio | 32.89 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 15,875 |
| Open | 3.80 |
| Previous Close | 3.80 |
| Day's Range | 3.75 - 3.82 |
| 52-Week Range | 3.75 - 22.00 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About QLI
Qilian International Holding Group Limited engages in the research, development, and production of active pharmaceutical ingredients (APIs) and traditional Chinese medicine derivative (TCMD) products in China. The company offers licorice products, including Gan Di Xin, an antitussive and expectorant medicine; Qilian Shan Licorice Extract, an ingredient for pharmaceutical companies to manufacture traditional licorice tablets; and Qilian Shan licorice liquid extract, a primary ingredient for medical preparation companies to produce compound licor...
Financial Performance
In 2020, QLI's revenue was $50.03 million, an increase of 8.54% compared to the previous year's $46.10 million. Earnings were $5.06 million, a decrease of -5.04%.
Financial StatementsNews
Qilian International Holding Group Limited Received Approval for Oxytetracycline API Export to Egypt
JIUQUAN, China, Oct. 13, 2021 /PRNewswire/ -- Qilian International Holding Group Limited (Nasdaq: QLI) (the "Company"), a China-based pharmaceutical and chemical products manufacturer, announced that on...
Qilian International Holding Group Limited Reports Financial Results for the First Six Months of Fiscal Year 2021
Jiuquan, China, Sept. 16, 2021 (GLOBE NEWSWIRE) -- Qilian International Holding Group Limited (Nasdaq: QLI) (the “Company”), a China-based pharmaceutical and chemical products manufacturer, today announ...
Qilian International Holding Group Limited Signs Agreement with District Government, Settling the Project in Local Hi...
Jiuquan, China, Aug. 05, 2021 (GLOBE NEWSWIRE) -- Qilian International Holding Group Limited (Nasdaq: QLI) (the “Company”), a China-based pharmaceutical and chemical products manufacturer, today announc...
Qilian International Holding Group Limited Enters into Investment Agreement for Pig By-product Processing Project in ...
Jiuquan, China, July 09, 2021 (GLOBE NEWSWIRE) -- Qilian International Holding Group Limited (Nasdaq: QLI) (the “Company”), a China-based pharmaceutical and chemical products manufacturer, today announc...
Qilian International Holding Group Limited Announces Inclusion of 16 Products into China's National Reimbursement Dru...
Jiuquan, China, April 13, 2021 (GLOBE NEWSWIRE) -- Qilian International Holding Group Limited (Nasdaq: QLI) (the “Company”), a China-based pharmaceutical and chemical products manufacturer, today announ...
Qilian International Holding Group Limited Reports Fiscal Year 2020 Financial Results
Jiuquan, China, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Qilian International Holding Group Limited (Nasdaq: QLI) (the “Company”), a China-based pharmaceutical and chemical products manufacturer, today announc...
Qilian International Holding Group Limited to Triple Organic Fertilizer Production Capacity by March 2021
Jiuquan, China, Feb. 08, 2021 (GLOBE NEWSWIRE) -- Qilian International Holding Group Limited (Nasdaq: QLI) (the “Company”), a China-based pharmaceutical and chemical products manufacturer, today announc...
Univest Securities, LLC. Announces Closing of IPO for its Client Qilian International Holding Group Limited (Nasdaq: ...
New York, Jan. 19, 2021 (GLOBE NEWSWIRE) -- Univest Securities, LLC (“Univest”), a member of FINRA and SIPC, is a full-service investment bank and securities broker-dealer firm based in New York, today ...
Qilian International Holding Group Limited Announces Closing of Initial Public Offering
Jiuquan, China, Jan. 14, 2021 (GLOBE NEWSWIRE) -- Qilian International Holding Group Limited (the “Company”) (Nasdaq: QLI), a China-based pharmaceutical and chemical products manufacturer, today announc...
Qilian IPO: 10 Things for Potential QLI Stock Investors to Know About the Chinese Pharma
Qilian (QLI) is catching the eyes of investors on Tuesday as shares of its stock started trading today via the company's IPO. The post Qilian IPO: 10 Things for Potential QLI Stock Investors to Know Abo...
Qilian International Holding Group Limited Announces Pricing of Initial Public Offering
Jiuquan, China, Jan. 11, 2021 (GLOBE NEWSWIRE) -- Qilian International Holding Group Limited (the “Company”), a China-based pharmaceutical and chemical products manufacturer, today announced the pricing...